With a dynamic team, a robust pipeline and a singular focus on animal health, VVC will build a global portfolio.
(PRWEB) June 26, 2013
At the VetHealth Global Conference in Charlottetown, Prince Edward Island, VetVenture Capital Inc. (VVC) announced the formation of the first venture capital fund focused exclusively on animal health.
With its first closing anticipated in the third quarter of 2013, VVC will leverage deep sector expertise and strong relationships throughout North and South America, Europe and Asia. VVC's initial fund size of $100 million will include leading strategic and financial investors.
As the first venture capital fund focused exclusively on animal health, VVC has a unique ability to take advantage of a proprietary pipeline and overlooked opportunities. Target investment areas will include products for the treatment and prevention of disease, and the optimization of health and wellness using traditional and non-traditional technologies.
The initial team will include leading industry experts including Dr Paul Dick and Seth Zalkin, Dr Murray McLaughlin and Dr. Oliver Fratzscher. Other industry leaders will be announced over the coming months and will ensure both a global reach and an unparalleled expertise.
VVC was founded to support the following market trends:
- The need for products to optimize the health and productivity of animals leading to the production of nutrient rich food to feed the growing global population;
- The need of companion animal pet owners to support the health of their dogs, cats and horses; and
- The need of the animal health industry to acquire and license new products, and acquire companies in order to meet corporate growth expectations.
With a dynamic team, a robust pipeline and a singular focus on animal health, VVC will build a global portfolio driven by the demand for improved efficiency and production of protein, and, the role of the pet in the family, with best in class technology and management.